ABC | Volume 112, Nº5, May 2019

Original Article Warpechowski Neto et al Hospital readmission – implantable devices Arq Bras Cardiol. 2019; 112(5):491-498 This is an open-access article distributed under the terms of the Creative Commons Attribution License 16. deOliveira JC, Martinelli M, Nishioka SA, Varejão T, Uipe D, Pedrosa AA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29-34. 17. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, et al; BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368(22):2084-93. 18. Cheng A, Nazarian S, Brinker JA, Tompkins C, Spragg DD, Leng CT, et al. Continuation of warfarin during pacemaker or implantable cardioverter- defibrillator implantation: a randomized clinical trial. Heart Rhythm. 2011;8(4):536-40. 19. Young JB, AbrahamWT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: theMIRACLE ICD Trial. JAMA. 2003;289(20):2685-94. 20. Rocha EA, Pereira FT, Abreu JS, Lima JW, Monteiro Mde P, Rocha Neto AC, et al. Development and validation of predictive models of cardiac mortality and transplantation in resynchronization therapy. Arq Bras Cardiol. 2015;105(4):399-409. 21. Silva KR, Albertini CM, Crevelari ES, Carvalho EI, Fiorelli AI, Martinelli M Filho, et al. Complications after surgical procedures in patients with cardiac implantable electronic devices: results of a prospective registry. Arq Bras Cardiol. 2016;107(3):245-56. 498